Search





Search





Markets
/
Stocks
/
cvkd
/

Cadrenal Therapeutics Inc

CVKD

Add to Watchlist

2.035USD

-0.055-2.63%

Close 07-31 16:00（ET）Quotes delayed by 15 min

5.10MMarket Cap

LossP/E TTM

Cadrenal Therapeutics Inc

2.035

-0.055-2.63%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

CVKD Balance Sheet

You can check out the annual or quarterly balance sheets of Cadrenal Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q2

Total equity

Cash, cash equivalents and short-term investments

-68.54%2.31M

-59.99%4.01M

-11.55%3.86M

10.59%5.57M

11.72%7.34M

19.23%10.02M

-52.09%4.36M

55.96%5.04M

63.00%6.57M

25685.61%8.40M

--9.11M

5314.96%3.23M

--4.03M

--32.59K

--59.65K

- Cash and cash equivalents

-68.54%2.31M

-59.99%4.01M

-11.55%3.86M

10.59%5.57M

11.72%7.34M

19.23%10.02M

-52.09%4.36M

55.96%5.04M

63.00%6.57M

25685.61%8.40M

--9.11M

5314.96%3.23M

--4.03M

--32.59K

--59.65K

Receivables

-77.84%5.47K

-86.64%5.10K

--12.79K

--19.04K

--24.66K

--38.15K

----

-Loans receivable

-77.84%5.47K

--5.10K

--12.79K

--19.04K

--24.66K

----

-Other receivables

----

--38.15K

----

Prepaid expenses

-25.63%428.07K

373.63%200.14K

-39.48%116.02K

52.53%358.36K

95.94%575.61K

-52.88%42.26K

13.70%191.71K

-18.80%234.95K

-28.51%293.77K

294.77%89.67K

--168.60K

944.84%289.33K

--410.90K

--22.71K

--27.69K

Other current assets

1244.30%113.61K

636.19%106.34K

-22.28%90.84K

-86.08%23.86K

-94.96%8.45K

--14.45K

--116.88K

--171.38K

--167.84K

-100.00%0.00

--0.00

-100.00%0.00

--0.00

--672.29K

--153.81K

Total current assets

-64.06%2.86M

-57.29%4.32M

-12.69%4.08M

9.71%5.97M

13.04%7.94M

19.08%10.11M

-49.64%4.67M

54.68%5.44M

58.31%7.03M

1067.15%8.49M

--9.28M

1359.31%3.52M

--4.44M

--727.60K

--241.15K

Non-current assets

Net Fixed Assets

-1.26%4.62K

-25.49%5.17K

90.27%5.73K

-56.69%4.28K

-71.84%4.68K

-70.18%6.94K

-89.89%3.01K

-72.65%9.88K

-57.41%16.61K

-47.78%23.29K

--29.78K

--36.10K

--39.00K

--44.59K

----

Other non-current assets

-42.85%2.17K

0.00%3.79K

0.03%3.79K

-36.66%3.79K

--3.79K

72.76%3.79K

--3.79K

--5.99K

--2.19K

Total non-current assets

-19.88%6.79K

-31.62%7.34K

16.07%7.90K

-52.85%6.44K

-58.48%8.47K

-60.35%10.74K

-79.74%6.80K

-65.74%13.67K

-52.33%20.40K

-46.46%27.08K

--33.57K

1717.40%39.89K

--42.79K

--50.58K

--2.19K

Total assets

-64.01%2.86M

-57.26%4.33M

-12.64%4.09M

9.55%5.98M

12.84%7.95M

18.83%10.12M

-49.75%4.68M

53.33%5.46M

57.26%7.05M

994.77%8.52M

--9.31M

1362.54%3.56M

--4.48M

--778.17K

--243.35K

Liabilities

Current liabilities

-Other payables

236.76%83.53K

-25.88%38.77K

-22.98%35.61K

62.08%60.88K

-83.57%24.80K

37.38%52.31K

22.27%46.24K

15.50%37.56K

286.54%150.99K

--38.08K

--37.82K

--32.52K

--39.06K

----

Accrued expenses

-70.83%156.62K

-20.42%898.55K

-2.59%702.93K

9.71%723.03K

85.30%536.96K

88.16%1.13M

100.96%721.65K

175.08%659.04K

31.81%289.78K

-30.51%600.13K

--359.10K

81.23%239.58K

--219.84K

--863.56K

--132.20K

Short-term debt and lease liabilities

----

-100.00%0.00

--0.00

--43.73K

----

-Short-term debt

----

-100.00%0.00

--0.00

--43.73K

----

Other current liabilities

236.76%83.53K

-25.88%38.77K

-22.98%35.61K

62.08%60.88K

-83.57%24.80K

37.38%52.31K

22.27%46.24K

15.50%37.56K

286.54%150.99K

--38.08K

--37.82K

--32.52K

--39.06K

----

Total current liabilities

-42.13%1.06M

-40.83%1.59M

6.77%1.35M

14.65%1.68M

114.89%1.84M

224.59%2.68M

124.81%1.27M

291.37%1.46M

113.21%856.32K

-38.04%826.88K

--563.57K

10.19%374.31K

--401.63K

--1.33M

--339.71K

Non-current liabilities

Long-term debt and lease liabilities

--0.00

-100.00%0.00

--2.23K

-97.93%8.80K

--15.17K

--574.69K

--424.96K

-Long-term debt

----

-100.00%0.00

--0.00

-100.00%0.00

--0.00

--553.34K

--424.96K

-Long-term lease liabilities

----

-100.00%0.00

--2.23K

--8.80K

--15.17K

--21.35K

----

Long-term accrued expenses

----

-100.00%0.00

--0.00

-100.00%0.00

--0.00

--40.21K

--8.54K

Derivatives liabilities

----

-100.00%0.00

--0.00

-100.00%0.00

--0.00

--4.38M

--140.98K

Other non-current liabilities

--0.00

----

--0.00

----

Total non-current liabilities

----

-100.00%0.00

--2.23K

-98.47%8.80K

--15.17K

--4.99M

--574.48K

Total liabilities

-42.13%1.06M

-40.83%1.59M

6.77%1.35M

14.65%1.68M

114.89%1.84M

224.59%2.68M

123.92%1.27M

282.38%1.46M

105.45%856.32K

-86.94%826.88K

--565.80K

-58.09%383.10K

--416.80K

--6.33M

--914.18K

Shareholders' equity

Common equity

21.22%43.25M

25.74%41.70M

54.95%38.66M

62.35%37.53M

55.63%35.68M

45.68%33.16M

10.03%24.95M

43.90%23.12M

43.71%22.93M

1857.03%22.76M

--22.67M

201998.44%16.07M

--15.95M

--1.16M

--7.95K

Retained earnings

-40.21%-41.46M

-51.46%-38.96M

-66.80%-35.92M

-73.76%-33.24M

-76.69%-29.57M

-70.67%-25.72M

-54.63%-21.54M

-48.38%-19.13M

-40.77%-16.73M

-124.47%-15.07M

---13.93M

-1799.11%-12.89M

---11.89M

---6.71M

---678.79K

Capital reserves

21.22%43.25M

25.74%41.70M

54.95%38.65M

62.45%37.53M

55.73%35.68M

45.76%33.16M

10.09%24.95M

43.90%23.10M

43.72%22.91M

1869.79%22.75M

--22.66M

--16.06M

--15.94M

--1.15M

--0.00

Total equity

-70.60%1.80M

-63.19%2.74M

-19.85%2.73M

7.68%4.30M

-1.28%6.11M

-3.29%7.44M

-60.98%3.41M

25.70%3.99M

52.32%6.19M

238.57%7.69M

--8.75M

573.43%3.18M

--4.07M

---5.55M

---670.84K

Currency unit

--USD

Audit opinions

----

FAQs

Which balance sheet metrics matter most when analyzing CVKD stock?



Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?



Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?



Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does Cadrenal Therapeutics Inc Have?



In its most recent quarterly, Cadrenal Therapeutics Inc had 2.31M in cash and cash equivalents.

What Are Cadrenal Therapeutics Inc's Total Assets?



As of the latest reported quarter, Cadrenal Therapeutics Inc's total assets were 4.33M, consisting of 4.32M in current assets and 7.34K in non-current assets.

How Much Shareholders' Equity Does Cadrenal Therapeutics Inc Have?



Cadrenal Therapeutics Inc reported 2.74M in total shareholders' equity as of the latest reported quarter.